Non-Small-Cell Lung Cancer: Practical Guidance for a Rapidly Evolving Treatment Paradigm

Download All
Review the latest data and expert guidance on managing patients with NSCLC. This comprehensive program features clinical commentaries, a downloadable patient communication resource, updates to the online, interactive treatment decision support tools, and a text-based module along with downloadable slides.
Matthew Gubens, MD, MS

Text Module

Review expert insights on the latest clinical data informing optimal management of patients with advanced NSCLC using targeted agents and immune checkpoint inhibitors.

Matthew Gubens, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 23, 2020 Expired: June 22, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Grace Logo
Supported by educational grants from
Bristol-Myers Squibb
Celgene Corporation
Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue